Skip to contentClarengateINTELLIGENCE
Companies/NI679559

Rapid-Myco Technologies Limited

Other research and experimental development on natural sciences and engineering · Belfast

ActiveUnited KingdomIncorporated 2021Private Limited Company
Register Ask analyst

Documents & history

Available account evidence and business events. This is not a complete filing history or document library.

Accounts to 2025-05-31

IXBRL · 69 source facts · 14 selected values

Validation clean
XBRL valid
Reporting period
2024-06-01 to 2025-05-31
Extraction status
complete
Numeric facts
15
Documents processed
1
XBRL standards validation
valid
Filing-profile validation
valid
Parser
arelle 2.44.4
Taxonomy
FRS-102-2024-01-01.xsd
Currency
GBP
Source identifier
Prod224_2602_NI679559_20250531
Source archive
Accounts_Monthly_Data-February2026.zip

Accounts to 2024-05-31

IXBRL · 36 source facts · 14 selected values

Validation findings
XBRL valid
Reporting period
2023-06-01 to 2024-05-31
Extraction status
complete
Numeric facts
16
Documents processed
1
XBRL standards validation
valid
Filing-profile validation
invalid
Parser
arelle 2.44.4
Taxonomy
FRS-102-2023-01-01.xsd
Currency
GBP
Source identifier
Prod224_3600_NI679559_20240531
Source archive
Accounts_Monthly_Data-February2025.zip

Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.

Registered details

NI679559
Status
Active
Type
Private Limited Company
Incorporated
2021-05-25
Jurisdiction
—
Registered office
C/O QUBIS LTD, 63 UNIVERSITY ROAD, BELFAST, BT7 1NF, NORTHERN IRELAND

Classification

3 SIC codes
721907490975000

Capital & company events

Reconstructed equity rounds and matched research funding.

Equity fundraising

2 SH01-derived rounds
2023-02-08
£114,978 raised
£3,399,760 estimated post-money
2022-12-20
£954,983 raised
£3,363,877 estimated post-money

Research and innovation

1 matched grants
Diagnosis of Crohn's disease cases with systemic MAP infections using novel RAPIDvMAP assayLead
Innovate UK · Launchpad · 2024-05-01 – 2026-03-31
£99,149
awarded